Cephalon Must Face Most Of FCA Off-Label Marketing Suit
A Pennsylvania federal judge allowed most of a False Claims Act case accusing Cephalon Inc. of a kickback scheme involving off-label drug marketing to continue Wednesday, saying the whistleblower had pled...To view the full article, register now.
Already a subscriber? Click here to view full article